Dr. Seth B. Forman, MD

Dr. Forman practices at Phdermatology in Palm Harbor, Florida.

Dr. Forman's NPI, 1346304540, was assigned on December 21, 2006. Dr. Forman graduated from VCU School of Medicine in 2002. Dr. Forman holds Florida license ME96509.

Dr. Forman's primary practice is Phdermatology, at 4197 Woodlands Pkwy, Palm Harbor, FL 34685-3493. The practice phone is (727) 786-3810.

Dr. Forman's primary practice is Phdermatology in Palm Harbor, Florida. The medical group on file is PHDermatology. Dmand AI also links Dr. Forman to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Forman practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Forman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Forman is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Forman's licenses on file in 3 states: Florida, Pennsylvania and Virginia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Forman treats.

CMS data shows 3,566 Medicare services from Dr. Forman across 15 procedure codes in 2024, for 743 Medicare patients. Medicare paid $127,374 for them. Every service was in an office.

CMS counts 743 Medicare patients who saw Dr. Forman in 2024. The largest group is 65 to 74, with 353 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Forman's median patient age at 69, with 47% women.

In 2024, Dr. Forman wrote 921 Medicare Part D claims for 325 patients. 80% of them were for generic drugs. CMS names the drug for 715 of them, across 17 drugs with 11 or more claims each, at $1,124,466 in total drug cost. In 2023, CMS named 670 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Forman for performance year 2024, reported as part of a group.

Dmand AI links 41 papers to Dr. Forman, published from 2018 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Double-Blind Method, Dermatitis, Atopic and Skin Neoplasms. Dr. Forman has published most often in J Am Acad Dermatol. Dr. Forman's most frequent co-authors are Eric Lawrence Simpson, MD, Lawrence F. Eichenfield, MD and Leon H. Kircik, MD.

Dmand AI links Dr. Forman to 34 clinical trials, 7 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic, Eczema and Skin Diseases, Eczematous. Eli Lilly and Company sponsors the most, 19. Open Payments lists research payments to Dr. Forman that name 20 trials.

CMS Open Payments shows 1,767 general payments to Dr. Forman from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Eli Lilly and Company paid the most, $313,704. It also lists 100 research payments totaling $415,173 from 2016 to 2023, naming 20 clinical trials.

Dmand AI lists 1 award for Dr. Forman, most recently CMS Stage 1 EHR in 2011.

Dr. Forman graduated from VCU School of Medicine in 2002.

Dr. Forman is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.